Does the media prefer BRKR or MTD?

In the previous week, Bruker had 5 more articles in the media than Mettler-Toledo International. MarketBeat recorded 9 mentions for Bruker and 4 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.30 beat Bruker's score of 0.80 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer RGEN or MTD?

In the previous week, Repligen and Repligen both had 4 articles in the media. Repligen's average media sentiment score of 1.46 beat Mettler-Toledo International's score of 1.30 indicating that Repligen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repligen 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TECH or MTD?

In the previous week, Bio-Techne had 19 more articles in the media than Mettler-Toledo International. MarketBeat recorded 23 mentions for Bio-Techne and 4 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.30 beat Bio-Techne's score of 0.93 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 9 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer A or MTD?

In the previous week, Agilent Technologies had 25 more articles in the media than Mettler-Toledo International. MarketBeat recorded 29 mentions for Agilent Technologies and 4 mentions for Mettler-Toledo International. Agilent Technologies' average media sentiment score of 1.56 beat Mettler-Toledo International's score of 1.30 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 26 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Mettler-Toledo International 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MTD or BIO?

In the previous week, Bio-Rad Laboratories had 2 more articles in the media than Mettler-Toledo International. MarketBeat recorded 6 mentions for Bio-Rad Laboratories and 4 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.30 beat Bio-Rad Laboratories' score of 1.01 indicating that Mettler-Toledo International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Rad Laboratories 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Mettler-Toledo International (MTD) Competitors

$1,417.73 -1.29 (-0.09%)

As of 08/17/2026 03:58 PM Eastern

Compare

MTD vs. BRKR, RGEN, TECH, A, and BIO

Should you buy Mettler-Toledo International stock or one of its competitors? Mettler-Toledo International's main competitors and comparable companies include Bruker (BRKR), Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), and Bio-Rad Laboratories (BIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Mettler-Toledo International compare to Bruker?

Bruker (NASDAQ:BRKR) and Mettler-Toledo International (NYSE:MTD) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.44B	2.56	-$8.60M	-$0.70	N/A
Mettler-Toledo International	$4.03B	7.06	$869.19M	$44.43	31.91

In the previous week, Bruker had 5 more articles in the media than Mettler-Toledo International. MarketBeat recorded 9 mentions for Bruker and 4 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.30 beat Bruker's score of 0.80 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 21.91% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	-2.35%	12.47%	4.91%
Mettler-Toledo International	21.91%	-1,212.14%	25.11%

Bruker has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market.

Bruker currently has a consensus target price of $56.64, suggesting a potential downside of 1.78%. Mettler-Toledo International has a consensus target price of $1,461.27, suggesting a potential upside of 3.07%. Given Mettler-Toledo International's higher probable upside, analysts clearly believe Mettler-Toledo International is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	2 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.57
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

79.5% of Bruker shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 27.2% of Bruker shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Mettler-Toledo International beats Bruker on 10 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Repligen?

Repligen (NASDAQ:RGEN) and Mettler-Toledo International (NYSE:MTD) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Mettler-Toledo International has a net margin of 21.91% compared to Repligen's net margin of 5.29%. Repligen's return on equity of 5.30% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repligen	5.29%	5.30%	3.79%
Mettler-Toledo International	21.91%	-1,212.14%	25.11%

Repligen currently has a consensus target price of $166.43, indicating a potential downside of 1.54%. Mettler-Toledo International has a consensus target price of $1,461.27, indicating a potential upside of 3.07%. Given Mettler-Toledo International's higher probable upside, analysts plainly believe Mettler-Toledo International is more favorable than Repligen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repligen	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	3 Strong Buy rating(s)	3.00
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

97.6% of Repligen shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.6% of Repligen shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Mettler-Toledo International has higher revenue and earnings than Repligen. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repligen	$738.26M	12.92	$48.89M	$0.73	231.56
Mettler-Toledo International	$4.03B	7.06	$869.19M	$44.43	31.91

In the previous week, Repligen and Repligen both had 4 articles in the media. Repligen's average media sentiment score of 1.46 beat Mettler-Toledo International's score of 1.30 indicating that Repligen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repligen	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Repligen has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market.

Summary

Repligen and Mettler-Toledo International tied by winning 8 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	9.33	$181.86M	$1.15	62.95
Mettler-Toledo International	$4.03B	7.06	$869.19M	$44.43	31.91

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Bio-Techne had 19 more articles in the media than Mettler-Toledo International. MarketBeat recorded 23 mentions for Bio-Techne and 4 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.30 beat Bio-Techne's score of 0.93 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	9 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bio-Techne presently has a consensus target price of $68.92, indicating a potential downside of 4.79%. Mettler-Toledo International has a consensus target price of $1,461.27, indicating a potential upside of 3.07%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, analysts clearly believe Mettler-Toledo International is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	1 Sell rating(s)	14 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Bio-Techne has a beta of 1.28, meaning that its share price is 28% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market.

Mettler-Toledo International has a net margin of 21.91% compared to Bio-Techne's net margin of 14.97%. Bio-Techne's return on equity of 13.23% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	14.97%	13.23%	10.61%
Mettler-Toledo International	21.91%	-1,212.14%	25.11%

Summary

Mettler-Toledo International beats Bio-Techne on 9 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Mettler-Toledo International has a net margin of 21.91% compared to Agilent Technologies' net margin of 19.55%. Agilent Technologies' return on equity of 24.33% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Mettler-Toledo International	21.91%	-1,212.14%	25.11%

Agilent Technologies presently has a consensus price target of $160.24, suggesting a potential upside of 7.79%. Mettler-Toledo International has a consensus price target of $1,461.27, suggesting a potential upside of 3.07%. Given Agilent Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe Agilent Technologies is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.89
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

95.1% of Mettler-Toledo International shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Agilent Technologies has higher revenue and earnings than Mettler-Toledo International. Agilent Technologies is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	6.04	$1.30B	$4.98	29.85
Mettler-Toledo International	$4.03B	7.06	$869.19M	$44.43	31.91

In the previous week, Agilent Technologies had 25 more articles in the media than Mettler-Toledo International. MarketBeat recorded 29 mentions for Agilent Technologies and 4 mentions for Mettler-Toledo International. Agilent Technologies' average media sentiment score of 1.56 beat Mettler-Toledo International's score of 1.30 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	26 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Mettler-Toledo International	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilent Technologies has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market.

Summary

Agilent Technologies beats Mettler-Toledo International on 10 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends.

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 30.3% of Bio-Rad Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Mettler-Toledo International currently has a consensus price target of $1,461.27, suggesting a potential upside of 3.07%. Bio-Rad Laboratories has a consensus price target of $343.33, suggesting a potential downside of 3.30%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, equities analysts clearly believe Mettler-Toledo International is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46
Bio-Rad Laboratories	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Bio-Rad Laboratories had 2 more articles in the media than Mettler-Toledo International. MarketBeat recorded 6 mentions for Bio-Rad Laboratories and 4 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.30 beat Bio-Rad Laboratories' score of 1.01 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Rad Laboratories	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market. Comparatively, Bio-Rad Laboratories has a beta of 1.06, meaning that its share price is 6% more volatile than the broader market.

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.03B	7.06	$869.19M	$44.43	31.91
Bio-Rad Laboratories	$2.58B	3.68	$759.90M	$8.25	43.04

Mettler-Toledo International has a net margin of 21.91% compared to Bio-Rad Laboratories' net margin of 8.59%. Bio-Rad Laboratories' return on equity of 3.54% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.91%	-1,212.14%	25.11%
Bio-Rad Laboratories	8.59%	3.54%	2.48%

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks.

Get Mettler-Toledo International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MTD vs. The Competition

Export

Metric	Mettler-Toledo International	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$28.43B	$9.57B	$7.03B	$24.35B
Dividend Yield	N/A	1.46%	2.56%	3.69%
P/E Ratio	31.91	61.08	270.86	30.51
Price / Sales	7.06	107.41	602.91	20.20
Price / Cash	28.59	26.11	28.87	20.48
Price / Book	-1,222.18	5.14	11.17	4.92
Net Income	$869.19M	$56.67B	$3.45B	$1.07B
7 Day Performance	-1.36%	-0.72%	0.63%	0.13%
1 Month Performance	8.22%	3.73%	2.10%	2.60%
1 Year Performance	7.78%	18.22%	61.61%	18.42%

Mettler-Toledo International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MTD Mettler-Toledo International	2.8917 of 5 stars	$1,417.73 -0.1%	$1,461.27 +3.1%	+7.8%	$28.43B	$4.03B	31.91	18,100	Positive News
BRKR Bruker	2.7868 of 5 stars	$56.32 +5.4%	$56.64 +0.6%	+72.0%	$8.13B	$3.50B	N/A	11,085	Dividend Announcement
RGEN Repligen	3.1516 of 5 stars	$163.17 -0.4%	$166.43 +2.0%	+35.9%	$9.25B	$738.26M	223.52	2,000	Positive News
TECH Bio-Techne	3.1414 of 5 stars	$72.12 -0.2%	$68.08 -5.6%	+35.1%	$11.32B	$1.22B	104.52	3,100	Earnings Report Dividend Announcement
A Agilent Technologies	4.8014 of 5 stars	$148.42 +1.7%	$159.35 +7.4%	+24.6%	$41.23B	$6.95B	29.80	18,100	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MTD) was last updated on 8/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Summary

How does Mettler-Toledo International compare to Repligen?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Which has higher earnings and valuation, BRKR or MTD?

Does the media prefer BRKR or MTD?

Is BRKR or MTD more profitable?

Which has more risk and volatility, BRKR or MTD?

Do analysts rate BRKR or MTD?

Do institutionals & insiders hold more shares of BRKR or MTD?

Summary

How does Mettler-Toledo International compare to Repligen?

Is RGEN or MTD more profitable?

Do analysts recommend RGEN or MTD?

Do insiders & institutionals believe in RGEN or MTD?

Which has higher earnings and valuation, RGEN or MTD?

Does the media prefer RGEN or MTD?

Which has more risk and volatility, RGEN or MTD?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Which has preferable valuation & earnings, TECH or MTD?

Do insiders & institutionals believe in TECH or MTD?

Does the media prefer TECH or MTD?

Do analysts rate TECH or MTD?

Which has more volatility and risk, TECH or MTD?

Is TECH or MTD more profitable?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Is A or MTD more profitable?

Do analysts prefer A or MTD?

Do insiders and institutionals believe in A or MTD?

Which has preferable earnings & valuation, A or MTD?

Does the media prefer A or MTD?

Which has more risk and volatility, A or MTD?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Do institutionals and insiders hold more shares of MTD or BIO?

Do analysts prefer MTD or BIO?

Does the media refer more to MTD or BIO?

Which has more risk and volatility, MTD or BIO?

Which has stronger earnings and valuation, MTD or BIO?

Is MTD or BIO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools